AGARWALEYE

Dr. Agarwals Health Care Share Price

₹353.60 -11.3 (-3.1%)

03 May, 2025 19:09

SIP TrendupStart SIP in AGARWALEYE

Start SIP

Performance

  • Low
  • ₹351
  • High
  • ₹368
  • 52 Week Low
  • ₹351
  • 52 Week High
  • ₹464
  • Open Price₹363
  • Previous Close₹365
  • Volume471,352

Investment Returns

  • Over 1 Month -18.8%
  • Over 3 Month -12.04%
  • Over 6 Month -12.04%
  • Over 1 Year -12.04%
SIP Lightning

Smart Investing Starts Here Start SIP with Dr. Agarwals Health Care for Steady Growth!

Invest Now

Dr. Agarwals Health Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 124.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 11,175
  • P/B Ratio
  • 7.4
  • Average True Range
  • 17.53
  • EPS
  • 2.84
  • Dividend Yield
  • 0
  • MACD Signal
  • -9.59
  • RSI
  • 23.9
  • MFI
  • 8.32

Dr. Agarwals Health Care Financials

Dr. Agarwals Health Care Technicals

EMA & SMA

Current Price
₹353.60
-11.3 (-3.1%)
pointer
  • stock-down_img
  • Bearish Moving Average 11
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹396.30
  • 50 Day
  • ₹408.67
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

357.68 Pivot Speed
  • R3 381.82
  • R2 375.13
  • R1 364.37
  • S1 346.92
  • S2 340.23
  • S3 329.47

What's your outlook on Dr. Agarwals Health Care?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Dr Agarwal’s Eye Hospitals operate across 13 Indian states and 3 Union Territories, with a flagship center in Chennai. Internationally, the group spans 9 African countries. They offer advanced treatments for cataracts, glaucoma, retina, cornea, and pediatric ophthalmology.

Dr. Agarwal's Health Care Ltd has an operating revenue of Rs. 1,599.66 Cr. on a trailing 12-month basis. An annual revenue growth of 33% is outstanding, Pre-tax margin of 11% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 20 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 23 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Dr. Agarwals Health Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-14 Quarterly Results

Dr. Agarwals Health Care F&O

Dr. Agarwals Health Care Shareholding Pattern

32.45%
3.84%
0.72%
17.32%
1.62%
44.05%

About Dr. Agarwals Health Care

  • NSE Symbol
  • AGARWALEYE
  • BSE Symbol
  • 544350
  • ISIN
  • INE943P01029

Similar Stocks to Dr. Agarwals Health Care

Dr. Agarwals Health Care FAQs

Dr. Agarwals Health Care share price is ₹353 As on 03 May, 2025 | 18:55

The Market Cap of Dr. Agarwals Health Care is ₹11175.2 Cr As on 03 May, 2025 | 18:55

The P/E ratio of Dr. Agarwals Health Care is 124.6 As on 03 May, 2025 | 18:55

The PB ratio of Dr. Agarwals Health Care is 7.4 As on 03 May, 2025 | 18:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23